JAMDA
May 27, 2023
Support for the PALTmed podcast series is brought to you by:
Tools, knowledge, and recognition to improve vaccination rates and protect residents and staff.
Showing 1 - 9 of 9 results
Spotlight
March 31, 2023
Optimizing the Use of Gabapentin: A Special Drive to Deprescribe Podcast
Medication optimization is a hot topic in post-acute and long-term care and a focus of AMDA’s very popular Drive to Deprescribe (D2D) initiative. Now practitioners have yet another opportunity to address their deprescribing challenges with a new quarterly D2D podcast. The first program addresses Optimizing...
Podcast
February 2, 2023
Optimizing Use of Gabapentin (D2D Special Edition)
JAMDA
November 17, 2022
Recent Hospitalization and Initiation of Antiepileptics Among Persons With Alzheimer’s Disease
Antiepileptic drugs (AEDs) are frequently prescribed for persons with Alzheimer’s disease (AD), but little is known on factors associated with AED initiation in this population. We investigated whether recent hospitalization is associated with AED initiation in persons with AD.
Podcast
October 7, 2022
JAMDA On-The-Go | September 2022 | Person-Centered Care, Trauma Informed Care, New Onset Seizures, and Transitions to Home Care
JAMDA
June 30, 2022
New Onset (Incidence) of Epilepsy and Seizures in Nursing Home Residents
The point prevalence of epilepsy is high in nursing homes (NH), but the incidence of epilepsy after admission is unknown. This study was done to determine the incidence of epilepsy/seizure (epi/sz) comorbid with other conditions in older adult NH residents.
JAMDA
September 4, 2021
Prognostic Features of Sporadic Creutzfeldt-Jakob Disease: An Analysis of Taiwan's Nationwide Surveillance
To study the prognostic features of Creutzfeldt-Jakob disease (CJD) and shed light on its future therapy.
JAMDA
January 7, 2019
Antiepileptic Drugs and Accumulation of Hospital Days Among Persons With Alzheimer's Disease
To compare the accumulation of hospital days between initiators and noninitiators of antiepileptic drugs (AEDs) among persons with Alzheimer's disease (AD).
JAMDA
March 2, 2018
